Measuring leftover fluid in hospitalized heart failure patients
Part of Heart & circulation clinical trials.
This study looks at how well we can measure leftover fluid in the body in people hospitalized for heart failure with fluid overload. It aims to help doctors better manage treatment and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and admitted to the hospital for worsening heart failure with fluid overload.
- During your stay, you have had at least one sign of fluid buildup, like swelling in your legs, fluid in your belly, visible neck veins, or fluid in your lungs on imaging.
- You have been treated with a strong IV water pill (like at least 40 mg of furosemide).
- You are not pregnant.
- You are not in a critical or dying condition.
- You have both kidneys, and you are able to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether drinking less fluid (restrictive) vs. the usual amount (liberal) helps people hospitalized with heart failure. It aims to find out which approach leads to better recovery and fewer symptoms.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This study looks at how your kidneys handle salt and water when you're treated for acute heart failure in the hospital. Researchers want to understand which patients recover well from fluid buildup and which might need different treatment approaches.
This study looks at different patterns of fluid buildup in people with acute heart failure. It aims to understand how these patterns relate to treatment with water pills (diuretics) and may help improve care.
This study tests a new way to manage fluid buildup in patients with a specific type of heart failure (HFpEF) who are in the hospital. It aims to improve how doctors remove excess fluid and help you feel better.
This trial tests a device designed to safely remove extra fluid from patients hospitalized with worsening heart failure. It may help those who are not responding well to standard water pills (diuretics).
Hear when a new Decompensated Chronic Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.